Recombinant Salmonella vaccines for biodefence

Vaccine

Volumn 24, Issue 15, 2006, Pages 2710-2717

  Atkins, Helen S ^a   Morton, Margaret ^a   Griffin, Kate F ^a   Stokes, Margaret G M ^a   Nataro, James P ^b   Titball, Richard W ^a,c  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Attenuated Salmonella; Biodefence; Salmonella vaccine

Indexed keywords

LIVE VACCINE; RECOMBINANT VACCINE; SALMONELLOSIS VACCINE; SUBUNIT VACCINE; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; BACTERIAL STRAIN; BIOLOGICAL WARFARE; GENE TECHNOLOGY; GENETIC STABILITY; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA TYPHI; SEROTYPE; VACCINE PRODUCTION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS;

BIOLOGICAL WARFARE; BIOTERRORISM; HUMANS; SALMONELLA; SALMONELLA VACCINES; VACCINES, SYNTHETIC;

EID: 33644915543     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.12.046     Document Type: Review

References (66)

1. J.D. Marshall Jr., P.J. Bartelloni, D.C. Cavanaugh, P.J. Kadull, and K.F. Meyer Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine J Infect Dis 129 1974 S19 S25
2. A.M. Friedlander, P.R. Pittman, and G.W. Parker Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax JAMA 282 1999 2104 2106
3. E.D. Williamson, S.M. Eley, K.F. Griffin, M. Green, P. Russell, and S.E.C. Leary A new improved sub-unit vaccine for plague: the basis for protection FEMS Immunol Med Microbiol 12 1995 223 230
4. D.G. Heath, G.W. Anderson Jr., J.M. Mauro, S.L. Welkos, G.P. Andrews, and J. Adamovicz Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine Vaccine 16 1998 1131 1137
5. J. Miller, B.W. McBride, R.J. Manchee, P. Moore, and L.W.J. Baillie Production and purification of recombinant protective antigen and efficacy against Bacillus anthracis Lett Appl Microbiol 26 1998 56 60
6. L. Cardenas, and J.D. Clements Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens Clin Microbiol Rev 5 1992 328 342
7. S.N. Chatfield, G. Dougan, and M. Roberts Progress in the development of multivalent oral vaccines based on live attenuated Salmonella E. Kurstak Modern vaccinology 1994 Plenum New York 55 86
8. C.E. Hormaeche, C.M.A. Khan, P. Mastroeni, B. Villarreal, G. Dougan, and M. Roberst Salmonella vaccines: mechanisms of immunity and their use as carriers of recombinant antigens D.A.A. Ala'Aldeen C.E. Hormaeche Molecular and clinical aspects of bacterial vaccine development 1995 John Wiley and Sons London 119 153
9. M.M. Levine, J. Galen, E. Barry, F. Noriega, S. Chatfield, and M. Sztein Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors J Bacteriol 44 1996 193 196
10. D.M. Hone, M.T. Shata, D.W. Pascual, and G.K. Lewis Mucosal vaccination with Salmonella vaccine vectors Y. Patterson Intracellular bacterial vaccine vectors: immunology, cell biology and genetics 1999 John Wiley and Sons London 171 222
11. H.S. Garmory, K.A. Brown, and R.W. Titball Salmonella vaccines for use in humans: present and future perspectives FEMS Microbiol Rev 2002 339 353
12. World Health Organisation. Public health response to biological and chemical weapons. Geneva: World Health Organisation; 2004.
13. C.O. Tacket, M.B. Sztein, G.A. Losonsky, S.S. Wasserman, J.P. Nataro, and R. Edelman Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans Infect Immun 65 1997 452 456
14. C.O. Tacket, M.B. Sztein, S.S. Wasserman, G. Losonsky, K.L. Kotloff, and T.L. Wyant Phase 2 clinical trial of attenuated Salmonella enterica serovar Typhi oral live vector vaccine CVD908-htrA in U.S. volunteers Infect Immun 68 2000 1196 1201
15. E.L. Hohmann, C.A. Oletta, K.P. Killeen, and S.I. Miller PhoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers J Infect Dis 173 1996 1408 1414
16. C.J. Vindurampulle, L.F. Cuberos, E.M. Barry, M.F. Pasetti, and M.M. Levine Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy Vaccine 22 2004 3744 3750
17. R. Anderson, G. Dougan, and M. Roberts Delivery of the Pertactin/P.69 polypeptide of Bordatella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response Vaccine 14 1996 1384 1390
18. P. Londoño-Arcila, D. Freeman, H. Kleanthous, A.M. O'Dowd, S. Lewis, and A.K. Turner Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen Infect Immun 70 2002 5096 5106
19. S. Foynes, J.L. Holley, H.S. Garmory, R.W. Titball, and N.F. Fairweather Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F Hc fragment Vaccine 21 2003 1052 1059
20. K.F. Griffin, R.J. Bedford, K. Townson, R.J. Phillpotts, S.G.P. Funnell, and M. Morton Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine FEMS Immunol Med Microbiol 43 2005 425 430
21. R.J. Phillpotts, L. O'Brien, R.A. Appleton, S. Carr, and A.M. Bennett Intranasal immunisation with defective adenovirus serotype 5 expressing the Venezuelan equine encephalitis virus E2 glycoprotein protects against airborne challenge with virulent virus Vaccine 23 2005 1615 1623
22. N. Orr, J.E. Galen, and M.M. Levine Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA Vaccine 19 2001 1697 1700
23. S.N. Chatfield, I.G. Charles, A.J. Makoff, M.D. Oxer, G. Dougan, and D. Pickard Use of the nirB promoter to direct stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single dose oral tetanus vaccine Biotechnology 10 1992 888 892
24. M. Roberts, J. Li, A. Bacon, and S.N. Chatfield Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters Infect Immun 66 1998 3080 3087
25. S.J. Dunstan, C.P. Simmons, and R.A. Strugnell Use of in vivo-inducible promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium Infect Immun 67 1999 5133 5141
26. H.L. Bullifent, K.F. Griffin, S.M. Jones, A. Yates, L. Harrington, and R.W. Titball Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters Vaccine 18 2000 2668 2676
27. P.C.F. Oyston, E.D. Williamson, S.E.C. Leary, S.M. Eley, K.F. Griffin, and R.W. Titball Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague Infect Immun 63 1995 563 568
28. R.W. Titball, A.M. Howells, P.C.F. Oyston, and E.D. Williamson Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague Infect Immun 65 1997 1926 1930
29. H.S. Garmory, M.W. Leckenby, K.F. Griffin, S.J. Elvin, R.R. Taylor, and M.G. Hartley Antibiotic-free plasmid stabilization by operator-repressor titration for live vaccine delivery with Salmonella Infect Immun 73 2005 2005 2011
30. S. Pistor, and G. Hobom OmpA haemagglutinin fusion protein for oral immunization with live attenuated Salmonella Res Microbiol 141 1990 879 881
31. S. Wu, D.W. Pascual, G.K. Lewis, and D.M. Hone Induction of mucosal and systemic responses against human immunodeficiency virus type 1 glycoprotein 120 in mice after oral immunization with a single dose of a Salmonella-HIV vector AIDS Res Hum Retrovirus 13 1997 1187 1194
32. D. O' Callaghan, A. Charbit, P. Martineau, C. Leclerc, S. Van der Werf, and C. Nauciel Immunogenicity of foreign peptides expressed in bacterial envelope proteins Res Microbiol 141 1990 963 969
33. A. Charbit, P. Martineau, J. Ronco, R. Leclerc, V. Lo-Man, and O.C.D. Michel Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins Vaccine 11 1993 1221 1228
34. 4 on the surface of the Salmonella enterica using the antutransporter MisL Infect Immun 70 2002 3611 3620
35. U. Kramer, K. Rizos, H. Apfel, I.B. Autenrieth, and C.T. Lattemann Autodisplay: development of an efficacious system for surface display of antigenic determinants in Salmonella vaccine strains Infect Immun 71 2003 1944 1952
36. K. Rizos, C.T. Lattemann, D. Bumann, T.F. Meyer, and T. Aebischer Autodisplay: efficacious surface exposure of antigenic ureA fragments from Helicobacter pylori in Salmonella vaccine strains Infect Immun 71 2003 6320 6328
37. B.D. Tzschaschel, C.A. Guzman, K.N. Timmis, and V. De Lorenzo An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of the Shiga-like toxin IieB subunit by Salmonella typhimurium aroA Nat Biotechnol 14 1996 765 769
38. H. Russmann, H. Shams, F. Poblete, Y. Fu, J.E. Galan, and R.O. Donis Delivery of epitopes by the Salmonella type III secretion system for vaccine development Science 281 1998 565 568
39. J.E. Galen, L. Zhao, M. Chinchilla, J.Y. Wang, M.F. Pasetti, and J. Green Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA Infect Immun 72 2004 7096 7106
40. H.S. Garmory, R.W. Titball, K.F. Griffin, U. Hahn, R. Böhm, and W. Beyer Salmonella enterica serovar Typhimurium expressing a chromosomally integrated copy of the Bacillus anthracis protective antigen gene protects mice against an anthrax spore challenge Infect Immun 71 2003 3831 3836
41. J.E. Galen, and M.M. Levine Can a 'flawless' live vector vaccine strain be engineered? Trends Microbiol 9 2001 372 376
42. D. Hone, S. Attridge, L. Van den Bosch, and J. Hackett A chromosomal integration system for stabilisation of heterologous genes in Salmonella based vaccine strains Microb Pathog 5 1988 407 418
43. R.A. Strugnell, D. Maskell, N. Fairweather, D. Pickard, A. Cockayne, and C. Penn Stable expression of foreign antigens from the chromosome of Salmonella typhimurium vaccine strains Gene 88 1990 57 63
44. R.A. Strugnell, G. Dougan, S. Chatfield, I. Charles, N. Fairweather, and J. Tite Characterisation of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordatella pertussis Infect Immun 60 1992 3994 4002
45. E. Lee, R. Platt, S. Kang, J.A. Roth, and G.J. Phillips Chromosomal integration and expression of the Escherichia coli K88 gene cluster in Salmonella enterica ser. Cholerasuis strain 54 Vet Microbiol 83 2001 177 183
46. H.V. McNeill, K.A. Sinha, C.E. Hormaeche, J.J. Lee, and C.M.A. Khan Development of a nonantibiotic dominant marker for positively selecting expression plasmids in multivalent Salmonella vaccines Appl Environ Microbiol 66 2000 1216 1219
47. J.E. Galen, J. Nair, J.Y. Wang, S.S. Wasserman, M.K. Tanner, and M.B. Sztein Optimization of plasmid maintenance in the attenuated live vaccine vector strain Salmonella typhi CVD 908-htrA Infect Immun 67 1999 6424 6433
48. C.M. Khan, B. Villarreal-Ramos, R.J. Pierce, G. Riveau, R. Demarco de Hormaeche, and H. McNeill Construction, expression, and immunogenicity of the Schistosoma mansoni P28 glutathione S-transferase expressed as a genetic fusion to tetanus toxin fragment C in a live Aro attenuated vaccine strain of Salmonella Proc Natl Acad Sci USA 91 1994 11261 11265
49. J.J. Lee, K.A. Sinha, J.A. Harrison, R. Demarco de Hormaeche, G. Riveau, and R.J. Pierce Tetanus fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase Infect Immun 68 2000 2503 2512
50. E.K. Jagusztyn-Krynicka, J.E. Clark-Curtiss, and R. Curtiss III Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological properties of the hybrid proteins Infect Immun 61 1993 1004 1015
51. L. Cárdenas, and J.D. Clements Development of mucosal protection against the heat-stable enterotoxin (ST) of Escherichia coli by oral immunization with a genetic fusion delivered by a bacterial vector Infect Immun 61 1993 4629 4636
52. S.E.C. Leary, K.F. Griffin, H.S. Garmory, E.D. Williamson, and R.W. Titball Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague Microb Pathog 23 1997 167 179
53. Z. Hindle, S.N. Chatfield, J. Phillimore, M. Bentley, J. Johnson, and C.A. Cosgrove Characterization of Salmonella enteritica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers Infect Immun 70 2002 3457 3467
54. J.E. Galen, O.G. Gomez-Duarte, and G.A. Losonsky A murine model of intranasal immunisation to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens Vaccine 15 1997 700 708
55. T.E. Pickett, M.F. Passetti, J.E. Galen, M.B. Sztein, and M.M. Levine In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors Infect Immun 68 2000 205 213
56. M. Morton, H.S. Garmory, S.D. Perkins, A.M. O'Dowd, K.F. Griffin, and A.K. Turner A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice Vaccine 22 2004 2524 2532
57. R. Germanier, and E. Fuer Isolation and characterization of Gal E mutant Ty21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine J Infect Dis 131 1975 553 558
58. A.J. McKenna, J.A. Bygraves, M.C. Maiden, and I.M. Feavers Attenuated typhoid vaccine Salmonella typhi Ty21a: fingerprinting and quality control Microbiology 141 1995 1993 2002
59. M.M. Levine, C.O. Tacket, and M.B. Sztein Host-Salmonella interaction: human trials Microb Infect 3 2001 1271 1279
60. S.R. Attridge, R. Davies, and J.T. LaBrooy Oral delivery of foreign antigens by attenuated Salmonella: consequences of prior exposure to the vector strain Vaccine 15 1997 155 162
61. M. Roberts, A. Bacon, J. Li, and S. Chatfield Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protetion from tetanus toxin in mice immunized with Salmonella strains expressing fragment C Infect Immun 67 1999 3810 3815
62. B.L. Whittle, and N.K. Verma The immune response to a B-cell epitope delivered by Salmonella is enhanced by prior immunological experience Vaccine 15 1997 1737 1740
63. J.X. Bao, and J.D. Clements Prior immunologic experience potentiates the subsequent antibody response when Salmonella strains are used as vaccine carriers Infect Immun 59 1991 3841 3845
64. J.J. Kohler, L.B. Pathangey, S.R. Gillespie, and T.A. Brown Effect of preexisting immunity to Salmonella on the immune response to recombinant Salmonella enterica serovar Typhimurium expressing a Porphyromonas gingivalis hemagglutinin Infect Immun 68 2000 3116 3120
65. C.J. Vindurampulle, and S.R. Attridge Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines Infect Immun 71 2003 287 297
66. W.G. Metzger, E. Mansouri, M. Kronawitter, S. Diescher, M. Soerensen, and R. Hurwitz Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers Vaccine 22 2004 2273 2277